EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.
You can subscribe to receive the EAHP EU Monitor by email here.
EAHP President Joan Peppard advises members to heighten their awareness of the Falsified Medicines Directive in 2016
Writing to national member associations, EAHP President Joan Peppard has encouraged hospital pharmacists in all EU and European Economic Area (EEA) countries to take time to familiarise themselves with the forthcoming impacts to practice arising from the 2011 Falsified Medicines Directive and ensure hospital pharmacy representation at the national level on the issue.
The Directive will bring about a new system in which all packages of medicine will be given a “unique identifier” via a 2D barcode on the outer packaging. This will be placed on the packaging at the manufacturing level, and the serialisation code then “checked in” to a repository marking the package as legitimate. Importantly for hospital pharmacy, this code must then be “checked out” at the end of the supply chain, before the medicine is dispensed or administered to patients. This scan both assures the pharmacist that the product is not counterfeit, while the “check out” ensures the 2D barcode can not be reused by counterfeiters. In practice, this means the hospital pharmacy will need to oversee scan checkouts of every package of medicine entering the hospital. The deadline for implementation will be a date in 2019.
As reported in the August 2015 edition of the EAHP EU Monitor, the European Commission has now published a ‘Delegated Act’ on how these scan verification processes should operate. The Delegated Act is a binding regulation that all EU Member State and EEA countries must comply with, or face potential penalties and proceedings from the Commission.
The Delegated Act makes clear that the hospital sector is expected to conduct verification checks of medicines, alongside colleagues in community pharmacy. However, flexibility is provided as to ‘when’ the hospital chooses to conduct the required scanning. For example, the hospital may determine to conduct the scanning at first entry, shortly prior to departure of the medicine from the dispensary to the ward, elsewhere, or at a combination of points depending on the product.
2016 will be an important year at a national level, with the overall systems of verification being constructed via “national medicines verification organisations”. In her letter to members, EAHP President Joan Peppard encouraged hospital pharmacists to ensure their voice is heard within these developments.
More information about the European Commission’s Delegated Act on implementing the Falsified Medicines Directive’s verification requirements is available here.
……………………………………………………………………………………………………………………………………………………………….
European Medicines Agency outlines plans for faster authorisation procedures for priority medicines
The European Medicines Agency (EMA) has set out plans to offer early and enhanced scientific and regulatory support to medicine developers where a potential medicine has been deemed “of major public health interest”. This would include medicines that “have the potential to benefit patients who presently have no treatment options, or that may offer a major therapeutic advantage over existing treatments“.
The additional support from the agency would include:
Following a public consultation on matters such as the eligibility criteria, the Agency intends to the launch the new scheme in the first quarter of 2016.
More information here.
Comments to the consultation may provided up to a deadline of 23 December 2015.
…………………………………………………………………………………………………………………………………………………………………………….
European Commission launches consultation on work life balance for working parents and caregivers
The European Commission is inviting views on how best to address the challenges of work-life balance faced by working parents and caregivers. The consultation takes the form of an online survey to which any member of the public and organisation may respond. The deadline for response is the 17th February 2016.
The initiative for the consultation comes from a publicly expressed desire by the Commission to “increase the participation of women in the labour market by improving the current EU legal and policy framework and adapting it to today’s labour market to allow for working parents and people with dependent relatives to better balance family and work life, allow for a greater sharing of care responsibilities between women and men, and to strengthen gender equality.”
The percentage of women in employment in 2014 was 63.5%, which is 11.5 percentage points off the Europe 2020 target agreed by EU Member States. Eurofound figures estimate the gender employment gap costs 325 billion euros to the EU, or 2.5 % of the EU GDP. The Commission view the primary factors in lower female labour market participation as a lack of possibilities to balance work and family responsibilities, including lack of affordable childcare, rigid working arrangements or absence of incentives for men to take more care responsibilities in their families.
The Commission’s survey seeks views on the potentially available measures to improve the labour market environment for working parents and caregivers, including issues such as family-related leave arrangements and flexible working arrangements.
More information here.
……………………………………………………………………………………………………………………………………………………………….
EJHP – Impact of clinical pharmacist intervention on length of stay in an acute admission unit
The online first edition of the European Journal of Hospital Pharmacy has recently published an original research article examining the impact of clinical pharmacist interventions on length of stay in an acute admission unit in Denmark.
The full article is available here: http://ejhp.bmj.com/content/early/2015/12/01/ejhpharm-2015-000767.full
